AP4 encodes a c-MYC-inducible repressor of p21

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 39, 2008, Pages 15046-15051

  Jung, Peter ^a,b   Menssen, Antje ^b   Mayr, Doris ^c   Hermeking, Heiko ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Colorectal cancer; DNA damage; p53; Progenitor cells; TGF beta

Indexed keywords

AP4 TRANSCRIPTION FACTOR; PROTEIN P21; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA BINDING PROTEIN; ENHANCER BINDING PROTEIN AP 4; ENHANCER-BINDING PROTEIN AP-4; MYC PROTEIN; MYC PROTEIN, HUMAN; REPRESSOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRON; KERATINOCYTE; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; UPREGULATION; CANCER STEM CELL; COLON TUMOR; DNA DAMAGE; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINOCYTES; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 54449095611     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0801773105     Document Type: Article

References (48)

1. Adhikary S, Eilers M (2005) Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6:635-645.
2. Alexandrow MG, Kawabata M, Aakre M, Moses HL (1995) Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1. Proc Natl Acad Sci USA 92:3239-3243.
3. Meyer N, Kim SS, Penn LZ (2006) The Oscar-worthy role of Myc in apoptosis. Semin Cancer Biol 16:275-287.
4. Dang CV, et al. (2006) The c-Myc target gene network. Semin Cancer Biol 16:253-264.
5. Berns K, Hijmans EM, Koh E, Daley GQ, Bernards R (2000) A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts. Oncogene 19:3330-3334.
6. Hu YF, Luscher B, Admon A, Mermod N, Tjian R (1990) Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev 4:1741-1752.
7. Mermod N, Williams TJ, Tjian R (1988) Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature 332:557-561.
8. Imai K, Okamoto T (2006) Transcriptional repression of human immunodeficiency virus type 1 by AP-4. J Biol Chem 281:12495-12505.
9. Kim MY, et al. (2006) A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells. Proc Natl Acad Sci USA 103:13074-13079.
10. Tsujimoto K, et al. (2005) Regulation of the expression of caspase-9 by the transcription factor activator protein-4 in glucocorticoid-induced apoptosis. J Biol Chem 280:27638-27644.
11. Venditti M, Iwasiow B, Orr FW, Shiu RP (2002) C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells. Int J Cancer 99:35-42.
12. Varshochi R, et al. (2005) ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line. J Biol Chem 280:3185-3196.
13. Wu S, et al. (2003) Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22:351-360.
14. Brugarolas J, et al. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557.
15. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
16. Waldman T, Lengauer C, Kinzler KW, Vogelstein B (1996) Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381:713-716.
17. Pardali K, Kowanetz M, Heldin CH, Moustakas A (2005) Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1). J Cell Physiol 204:260-272.
18. Larsson LG, et al. (1988) Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene. Proc Natl Acad Sci USA 85:2638-2642.
19. Andersen RD, et al. (1987) Metal-dependent binding of a factor in vivo to the metal-responsive elements of the metallothionein 1 gene promoter. Mol Cell Biol 7:3574-3581.
20. Sansom OJ, et al. (2004) Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 18:1385-1390.
21. van de Wetering M, et al. (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241-250.
22. Polyak K, Hamilton SR, Vogelstein B, Kinzler KW (1996) Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathol 149:381-387.
23. Doglioni C, et al. (1996) p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: Its relationship with differentiation. J Pathol 179:248-253.
24. He TC, et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
25. Sansom OJ, et al. (2007) Myc deletion rescues Apc deficiency in the small intestine. Nature 446:676-679.
26. Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL (2002) Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens. Cancer Res 62:3126-3131.
27. Mukherjee S, Conrad SE (2005) c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells. J Biol Chem 280:17617-17625.
28. Ou SH, Garcia-Martinez LF, Paulssen EJ, Gaynor RB (1994) Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function. J Virol 68:7188-7199.
29. Gartel AL, Radhakrishnan SK (2005) Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 65:3980-3985.
30. Herold S, et al. (2002) Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol Cell 10:509-521.
31. Gartel AL, et al. (2001) Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci USA 98:4510-4515.
32. Siegel PM, Massague J (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3:807-821.
33. Bierie B, Moses HL (2006) TGF-beta and cancer. Cytokine Growth Factor Rev 17:29-40.
34. Iavarone A, Massague J (1997) Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature 387:417-422.
35. Massague J, Blain SW, Lo RS (2000) TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
36. van den Brink GR, Offerhaus GJ (2007) The morphogenetic code and colon cancer development. Cancer Cell 11:109-117.
37. Freytag SO (1988) Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol Cell Biol 8:1614-1624.
38. Schmid P, Schulz WA, Hameister H (1989) Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos. Science 243:226-229.
39. Asada M, Yamada T, Fukumuro K, Mizutani S (1998) p21Cip1/WAF1 is important for differentiation and survival of U937 cells. Leukemia 12:1944-1950.
40. Asada M, et al. (1999) Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J 18:1223-1234.
41. Steiner P, et al. (1995) Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J 14:4814-4826.
42. Hermeking H, Funk JO, Reichert M, Ellwart JW, Eick D (1995) Abrogation of p53-induced cell cycle arrest by c-Myc: Evidence for an inhibitor of p21WAF1/CIP1/SDI1. Oncogene 11:1409-1415.
43. Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B (1996) Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J 15:6595-6604.
44. Seoane J, Le HV, Massague J (2002) Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419:729-734.
45. Jung P, et al. (2007) Induction of cullin 7 by DNA damage attenuates p53 function. Proc Natl Acad Sci USA 104:11388-11393.
46. Tarasov V, et al. (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6:1586-1593.
47. Menssen A, et al. (2007) c-MYC Delays Prometaphase by Direct Transactivation of MAD2 and BubR1: Identification of Mechanisms Underlying c-MYC-Induced DNA Damage and Chromosomal Instability. Cell Cycle 6:339-352.
48. Hermeking H, et al. (2000) Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci USA 97:2229-2234.